Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy

Status:
Completed

Trial end date:
2017-09-01

Target enrollment:

Participant gender:

To evaluate efficacy of different intravitreal Conbercept injection therapy in the treatment of severe proliferative diabetic retinopathy.

Phase 4

Ruijin Hospital